Characterization and gastroprotective effects of Rosa brunonii Lindl. fruit on gastric mucosal injury in experimental rats – A preliminary study

  • Ejaz Ahmad Department of Chemistry, GC University Lahore, Pakistan
  • Muhammad Jahangeer Department of Chemistry, GC University Lahore, Pakistan
  • Zahid Mahmood Akhtar Department of Pathology, Gujranwala Medical College, Gujranwala, Pakistan
  • Tariq Aziz Department of Agriculture, University of Ioannina, 47100 Arta, Greece
  • Metab Alharbi Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
  • Abdulrahman Alshammari Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
  • Abdullah F. Alasmari Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
  • Nadeem Irfan Bukhari University College of Pharmacy, University of the Punjab, Lahore, Pakistan
DOI: https://doi.org/10.18388/abp.2020_6772

Abstract

Gastric ulcer is the most prevalent disorder affecting a large population. Rosa brunonii Lindl. fruit (RBF) has traditionally been used to treat stomach pains. Therefore, the current work aimed to isolate, characterize, and investigate the gastro-protective effect of Rosa brunonii Lindl. fruit chloroform extract (RBFCE) against ethanol-induced gastric ulcers in rats. Quercetin 3-O-glucoside (QUE-G) was isolated and characterized by modern spectroscopic techniques. RBFCE was orally administered at 250 mg/kg, 500 mg/kg, and 750 mg/kg doses for ten days. Gastric ulcer was induced by a single dose of absolute ethanol (5 ml/kg) on the last day of the study. Histological changes were calculated, along with ulcer inhibition and the ulcer index (UI). Gastric juice volume, pH, acidity, mucus content, and protein content were evaluated to understand the mechanism underlying its gastroprotective effect. Omeprazole (OMP) was used as the positive control. RBFCE at a dose of 750 mg/kg significantly (p<0.01) reduced the UI (3.54) and increased the protection rate (67.63%) compared to the negative (ulcer) control group. Treatment with RBFCE in a dose-dependent manner increased the gastric pH, mucus content, and total protein while decreasing gastric juice volume and total acidity. Histopathological studies showed severe gastric mucosal injury and edema in ulcer control animals compared to extract-treated groups. This study demonstrated that oral administration of RBFCE possesses a significant gastroprotective effect due to its anti-secretory and cytoprotective mechanisms. Our findings support the traditional use of RBF to treat the gastric ulcer.

Published
2023-08-18
Issue
Vol. 70 No. 3 (2023)
Section
Articles

Copyright (c) 2023 Ejaz Ahmad, Muhammad Jahangeer, Zahid Mahmood Akhtar, Tariq Aziz, Metab Alharbi, Abdulrahman Alshammari, Abdullah F. Alasmari, Nadeem Irfan Bukhari

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Acta Biochimica Polonica is an OpenAccess quarterly and publishes four issues a year. All contents are distributed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY 4.0) license. Everybody may use the content following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Copyright for all published papers © stays with the authors.

Copyright for the journal: © Polish Biochemical Society.